Analyzing Aspyra (OTCMKTS:APYI) and American Well (NYSE:AMWL)

Aspyra (OTCMKTS:APYI) and American Well (NYSE:AMWL) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.

Volatility and Risk

Aspyra has a beta of 1.91, suggesting that its share price is 91% more volatile than the S&P 500. Comparatively, American Well has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500.

Institutional & Insider Ownership

56.1% of American Well shares are owned by institutional investors. 23.9% of Aspyra shares are owned by insiders. Comparatively, 12.8% of American Well shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Aspyra and American Well, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aspyra	0	0	0	0	0.00
American Well	1	6	1	0	2.00

American Well has a consensus target price of $9.17, indicating a potential upside of 46.20%. Given American Well’s stronger consensus rating and higher probable upside, analysts clearly believe American Well is more favorable than Aspyra.

Earnings and Valuation

This table compares Aspyra and American Well”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aspyra	N/A	N/A	N/A	N/A	N/A
American Well	$254.36 million	0.40	-$208.14 million	($8.07)	-0.78

Aspyra has higher earnings, but lower revenue than American Well.

Profitability

This table compares Aspyra and American Well’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aspyra	N/A	N/A	N/A
American Well	-46.15%	-41.99%	-30.80%

About Aspyra

Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company was formerly known as Creative Computer Applications Inc. and changed its name to Aspyra Inc. in November 2005. Aspyra Inc. was founded in 1978 and is headquartered in Jacksonville, Florida.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.